Legal Opinion
United States ex rel. Solis v. Millennium Pharm., Inc.
Court of Appeals for the Ninth Circuit
Decided March 15, 2018No. 15-16953; No. 15-17055; No. 15-17057PublishedCited by 23 opinions
1Opinion of the Court
WALLACE, Circuit Judge:
*625Frank Solis appeals from the dismissal of his False Claims Act action against three pharmaceutical companies. We have jurisdiction under 28 U.S.C. § 1291, and we affirm in part and vacate and remand in part.
I
Millennium Pharmaceuticals, Inc. hired Solis to promote sales of a cardiovascular drug, Integrilin. He moved to Schering-Plough Corp. after Schering acquired the right to market Integrilin. There, he also promoted an antibiotic drug, Avelox. Schering later merged with Merck & Co., and Merck fired Solis a year later.
Solis filed this action in 2009. He alleged that…
2Cases cited8 opinions
- United States v. United Healthcare Insurance Co.Court of Appeals for the Ninth Circuit · 2016
- Chen-Cheng Wang, AKA C.C. Wang, an Individual and Ex Rel. The United States of America v. Fmc CorporationCourt of Appeals for the Ninth Circuit · 1992
- Ebeid Ex Rel. United States v. LungwitzCourt of Appeals for the Ninth Circuit · 2010
- United States Ex Rel. Hartpence v. Kinetic Concepts, Inc.Court of Appeals for the Ninth Circuit · 2015
- United States Ex Rel. Kelly v. Serco, Inc.Court of Appeals for the Ninth Circuit · 2017
3 more not listed; retrieve them via the Exa API.
3Cited by23 opinions
- United States v. SteppCourt of Appeals for the Sixth Circuit · 2012
- United States v. GarridoCourt of Appeals for the Sixth Circuit · 2006
- Zachary Silbersher v. Allergan, Inc.Court of Appeals for the Ninth Circuit · 2022
- Zachary Silbersher v. Valeant Pharmaceuticals Int'lCourt of Appeals for the Ninth Circuit · 2023
- Bank of New York Mellon v. Scott StafneCourt of Appeals for the Ninth Circuit · 2020
18 more not listed; retrieve them via the Exa API.